Development of adult IV PBPK models of lisinopril

MR Memoona Rashid
MS Muhammad Sarfraz
MA Mosab Arafat
AH Amjad Hussain
NA Nasir Abbas
MS Muhammad Waqas Sadiq
MR Muhammad Fawad Rasool
NB Nadeem Irfan Bukhari
request Request a Protocol
ask Ask a question
Favorite

A previously reported systematic approach [14, 35] was adopted for the development and validation of adult PBPK model of lisinopril (Fig. 1). For the development of PBPK model, all the population and drug specific parameters, including that of physicochemical and absorption, distribution metabolism and excretion (ADME), shown in Table 1 and Table 2 were entered as inputs under the respective nodes of PK-Sim.

Developmental strategy for lisinopril PBPK model

Physiological and biological input parameters for PK-Sim Simulation

47±8.3ml/min

2.82±0.0083L/h

Characteristics of the healthy population used for lisinopril PBPK model development

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A